Australia markets closed

Karyopharm Therapeutics Inc. (KPTI)

NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
1.06000.0000 (0.00%)
At close: 04:00PM EDT
1.0900 +0.03 (+2.83%)
After hours: 06:54PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
52,231
135,188
190,459
85,918
Other short-term investments
139,212
142,779
38,156
163,322
Total cash
191,443
277,967
228,615
249,240
Net receivables
26,962
47,086
22,497
12,881
Inventory
3,043
4,224
4,106
2,644
Other current assets
11,813
19,821
14,039
-
Total current assets
233,921
350,162
275,606
276,531
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
11,447
14,022
15,614
16,770
Accumulated depreciation
-6,565
-6,645
-6,057
-5,188
Net property, plant and equipment
4,882
7,377
9,557
11,582
Equity and other investments
-
-
0
24,215
Other long-term assets
1,635
633
20,142
722
Total non-current assets
6,517
8,010
29,699
36,519
Total assets
240,438
358,172
305,305
313,050
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
3,123
2,773
1,603
4,450
Accrued liabilities
44,884
38,790
49,434
52,930
Deferred revenues
-
-
0
297
Other current liabilities
1,654
1,848
678
609
Total current liabilities
69,479
65,908
73,718
60,203
Non-current liabilities
Long-term debt
170,919
170,105
169,293
117,928
Deferred revenues
-
-
-
0
Other long-term liabilities
978
-
-
-
Total non-current liabilities
307,165
308,920
311,260
202,301
Total liabilities
376,644
374,828
384,978
262,504
Stockholders' equity
Common stock
12
12
8
7
Retained earnings
-1,487,038
-1,343,939
-1,178,648
-1,069,611
Accumulated other comprehensive income
-161
-638
191
518
Total stockholders' equity
-136,206
-16,656
-79,673
50,546
Total liabilities and stockholders' equity
240,438
358,172
305,305
313,050